Page 67 - MEMORIA ANUAL 2019 SEHH-FEHH

Programa EsPañol dE TraTamiEnTos En HEmaTología (PETHEma)
MEMORIA ANUAL 2019
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
• Lahuerta JJ, Jiménez-Ubieto A, Paiva B, Martínez-López J, González-Medina J, Ló- pez-Anglada L, Cedena MT, Puig N, Oriol A, Blanchard MJ, Ríos R, Martín J, Martínez R, Sureda A, Hernández MT, de la Rubia J, Krsnik I, Cabañas V, Palomera L, Bargay J, Mateos MV, Rosiñol L, San Miguel JF, Bladé J. Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease. Blood. 2019 Jun 20;133(25):2664-8. doi: 10.1182/blood.2019000671.
• Higuero Saavedra V, González-Calle V, Sobejano E, Sebastiá J, Cabrero M, Basti- da JM, Puig N, Ocio EM, Mateos MV. Drug-induced Thrombotic Microangiopathy During Maintenance Treatment in a Patient With Multiple Myeloma. Hemasphere. 2019 Jun 4;3(3):e192. doi: 10.1097/HS9.0000000000000192.
• Giebel S, Marks DI, Boissel N, Baron F, Chiaretti S, Ciceri F, Cornelissen JJ, Doubek M, Esteve J, Fielding A, Foa R, Gorin NC, Gökbuget N, Hallböök H, Hoelzer D, Para- vichnikova E, Ribera JM, Savani B, Rijneveld AW, Schmid C, Wartiovaara-Kautto U, Mohty M, Nagler A, Dombret H. Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2019 Jun;54(6):798-809. doi: 10.1038/s41409-018-0373-4.
• Ossenkoppele G, Montesinos P. Challenges in the diagnosis and treatment of secondary acute myeloid leukemia. Crit Rev Oncol Hematol. 2019 Jun;138:6-13. doi: 10.1016/j.critrevonc.2019.03.003.
• Barba P, Elorza I. Allogeneic stem cell transplantation in the era of novel thera- pies for acute lymphoblastic leukaemia. Med Clin (Barc). 2019 Jul 5;153(1):28-34. English, Spanish. doi: 10.1016/j.medcli.2019.01.017.
• Algarín EM, Díaz-Tejedor A, Mogollón P, Hernández-García S, Corchete LA, San- Segundo L, Martín-Sánchez M, González-Méndez L, Schoumacher M, Banquet S, Kraus-Berthier L, Kloos I, Derreal A, Halilovic E, Maacke H, Gutiérrez NC, Mateos MV, Paíno T, Garayoa M, Ocio EM. Preclinical evaluation of the simultaneous in- hibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma. Haematologica. 2020 Mar;105(3):e116-e120. doi: 10.3324/ haematol.2018.212308.
67